文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

左心室质量指数对重度主动脉瓣狭窄结局的影响

Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
PubMed 文献 · Heart · 2017-07-06

该回顾性多中心注册研究纳入日本3282例重度主动脉瓣狭窄患者,分析高左心室质量指数(LVMI)的相关因素及其对结局的影响。结果显示高LVMI与保守治疗患者5年不良结局风险显著增加相关(HR 1.53),而初始主动脉瓣置换(AVR)组无显著差异,治疗策略与LVMI风险存在显著交互作用。

要点

  • 高LVMI在保守治疗的重度AS患者中与不良结局风险独立相关。
  • 初始AVR可消除高LVMI带来的额外风险,交互作用显著。
  • 女性、贫血、高血压等是高LVMI的相关因素。

核心结论

  • 高LVMI对保守治疗的重度AS患者结局有不良影响,但初始AVR患者中未观察到该影响。

研究设计与样本

  • 回顾性多中心注册研究,纳入日本3282例有LVMI数据的重度AS患者,管理策略由主治医师决定。

主要发现

  • 高LVMI(n=2374)的相关因素包括女性、BMI≥22、无血脂异常、LVEF<50%、Vmax≥4 m/s、瓣膜反流、高血压、贫血和终末期肾病。
  • 保守治疗队列中,高LVMI组(n=1480)较正常LVMI组(n=691)调整后5年风险显著增加(HR 1.53,95%CI 1.26-1.85,p<0.001)。
  • 初始AVR队列中,高LVMI组(n=894)与正常LVMI组(n=217)风险无显著差异(HR 0.96,95%CI 0.60-1.55,p=0.88)。
  • 初始治疗策略与高LVMI风险存在显著交互作用(p=0.016)。

关键数值与推荐

  • 高LVMI定义为男性LVMI>115 g/m2,女性LVMI>95 g/m2。
  • 主要结局为主动脉瓣相关死亡和心力衰竭住院的复合终点。

临床怎么用

  • 对重度AS合并高LVMI患者,初始AVR可能消除高LVMI带来的额外不良结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate the factors associated with high left ventricular mass index (LVMI) and to test the hypothesis that high LVMI is associated with worse outcome in severe aortic stenosis (AS). METHODS: We analysed 3282 patients with LVMI data in a retrospective multicentre registry enrolling consecutive patients with severe AS in Japan. The management strategy, conservative or initial aortic valve replacement (AVR), was decided by the attending physician. High LVMI was defined as LVMI >115 g/m2 for males and >95 g/m2 for females. We compared the risk between normal and high LVMI in the primary outcome measures compromising aortic valve-related death and heart failure hospitalisation. RESULTS: Age was mean 77 (SD 9.6) years and peak aortic jet velocity (Vmax) was 4.1 (0.9) m/s. The factors associated with high LVMI (n=2374) included female, body mass index ≥22, absence of dyslipidemia, left ventricular ejection fraction <50%, Vmax ≥4 m/s, regurgitant valvular disease, hypertension, anaemia and end-stage renal disease. In the conservative management cohort (normal LVMI: n=691, high LVMI: n=1480), the excess adjusted 5-year risk of high LVMI was significant (HR: 1.53, 95% CI 1.26 to 1.85, p<0.001). In the initial AVR cohort (normal LVMI: n=217, high LVMI: n=894), the risk did not differ significantly between the two groups (HR: 0.96, 95% CI 0.60 to 1.55, p=0.88). There was a significant interaction between the initial treatment strategy and the risk of high LVMI (p=0.016). CONCLUSIONS: The deleterious impact of high LVMI on outcome was observed in patients managed conservatively, but not observed in patients managed with initial AVR. TRIAL REGISTRATION NUMBER: UMIN000012140; Post-results.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Minamino-Muta E, Kato T, Morimoto T, et al. Impact of the left ventricular mass index on the outcomes of severe aortic stenosis. Heart. 2017. PMID: 28684442. doi:10.1136/heartjnl-2016-311022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。